Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · The Lancet · 1,818 citations
https://doi.org/10.1016/s0140-6736(21)00676-0
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
2
Papers
0
Citations
0
h-index
0
i10-index
Deepak Rao is an academic researcher from King's College Hospital. The author has contributed to research in topics: Lung Cancer Diagnosis and Treatment & Lung Cancer Treatments and Mutations & Global Cancer Incidence and Screening.
https://doi.org/10.1016/s0140-6736(21)00676-0
https://doi.org/10.1016/s0140-6736(21)00149-5
Click to start Chat